Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

statnews.com

STAT

Get the latest updates from STAT directly as they happen.

Follow now 230 followers

Latest posts

Last updated about 9 hours ago

STAT+: French regulator fines Novo and Lilly over weight loss ad campaigns

about 9 hours ago

As competition mounts in the red-hot market for weight loss drugs, France’s...

Opinion: Mifepristone court ruling makes drug development riskier for everyone

about 10 hours ago

The biotech industry has long operated on a simple premise: FDA-regulated, evidence-based...

Supreme Court restores access to abortion pill mifepristone through telehealth, mail, and pharmacies

about 12 hours ago

WASHINGTON — The Supreme Court on Monday restored broad access to the...

Researchers urge study of paternal deaths, though a new paper finds fatherhood is protective

about 12 hours ago

Maternal health is a known crisis in the U.S., where pregnant women...

Pump the brakes on AI, buddy; and deposition deadlock

about 13 hours ago

This is the online version of STAT’s weekly email newsletter Health Care...

UCB to acquire maker of antibody treatments for autoimmune diseases

about 13 hours ago

Want to stay on top of the science and politics driving biotech...

What to know about hantavirus, the illness suspected in a cruise ship outbreak

about 13 hours ago

ALBUQUERQUE, N.M. — A rodent-borne illness is suspected of causing an outbreak...

STAT+: Pharmalittle: We’re reading about an abortion pill controversy, another UCB deal, and more news

about 13 hours ago

Good morning, everyone, and welcome to another working week. We hope the...

Federal court blocks mailing of mifepristone

about 14 hours ago

Get your daily dose of health and medicine every weekday with STAT’s...

STAT+: Biotech raises $42 million to run Huntington’s disease trial

about 16 hours ago

Gene therapy startup Latus Bio has raised another $42 million to start...

Opinion: Are blue zones real? Answering that question is harder than ever

about 19 hours ago

When French geneticist Jean-Francois Deleuze first launched the AGENOMICS study in 2022...

Immigration changes are driving foreign researchers to leave the U.S. — or not come to begin with

about 19 hours ago

The budding scientist had left India for the U.S. for her Ph.D...